Date:04/03/2003 URL: http://www.thehindu.com/2003/03/04/stories/2003030401271800.htm

Business - Monitor

Ranbaxy gets USFDA nod

MUMBAI: Ranbaxy Laboratories (RLL) has announced that Ranbaxy Pharmaceuticals Inc (RPI), a wholly owned subsidiary of RLL has received tentative approval from the U.S. Food and Drug Administration to market benazepril hydrochloride tablets in 5mg, 10mg, 20mg and 40mg strengths. In 2002, sales of this dosage totalled $332.50 million, according to a BSE release.